Hopkins Lupus Cohort

1999 Update

Research output: Contribution to journalArticle

Abstract

The Hopkins Lupus Cohort is a decade-long prospective study, now numbering 800 patients with systemic lupus erythematosus. In this article, predictors of disease activity, disease damage (including accelerated atherosclerosis and antiphospholipid antibody syndrome) and health status are reviewed.

Original languageEnglish (US)
Pages (from-to)199-213
Number of pages15
JournalRheumatic Disease Clinics of North America
Volume26
Issue number2
StatePublished - 2000

Fingerprint

Antiphospholipid Syndrome
Systemic Lupus Erythematosus
Health Status
Atherosclerosis
Prospective Studies

ASJC Scopus subject areas

  • Rheumatology

Cite this

Hopkins Lupus Cohort : 1999 Update. / Petri, Michelle.

In: Rheumatic Disease Clinics of North America, Vol. 26, No. 2, 2000, p. 199-213.

Research output: Contribution to journalArticle

@article{7d2bad84696b4fe899d61792eaa0c8db,
title = "Hopkins Lupus Cohort: 1999 Update",
abstract = "The Hopkins Lupus Cohort is a decade-long prospective study, now numbering 800 patients with systemic lupus erythematosus. In this article, predictors of disease activity, disease damage (including accelerated atherosclerosis and antiphospholipid antibody syndrome) and health status are reviewed.",
author = "Michelle Petri",
year = "2000",
language = "English (US)",
volume = "26",
pages = "199--213",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Hopkins Lupus Cohort

T2 - 1999 Update

AU - Petri, Michelle

PY - 2000

Y1 - 2000

N2 - The Hopkins Lupus Cohort is a decade-long prospective study, now numbering 800 patients with systemic lupus erythematosus. In this article, predictors of disease activity, disease damage (including accelerated atherosclerosis and antiphospholipid antibody syndrome) and health status are reviewed.

AB - The Hopkins Lupus Cohort is a decade-long prospective study, now numbering 800 patients with systemic lupus erythematosus. In this article, predictors of disease activity, disease damage (including accelerated atherosclerosis and antiphospholipid antibody syndrome) and health status are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=0034087160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034087160&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 199

EP - 213

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 2

ER -